Trademarkia Logo

Australia

AU$
OFEZUMIR
Protected: Registered/protected

Last updated on 18 Jul 2023

Owner Info

Incyte Holdings Corporation

1801 Augustine Cut-Off

Wilmington DE 19803, UNITED STATES OF AMERICA

Serial Number

2353852 filed on 31 Mar 2023

Correspondent

Frances M. Jagla Christensen O'Connor Johnson Kindness

1201 Third Avenue, Suite 3600,

Seattle WA 98101,

UNITED STATES OF AMERICA

OFEZUMIR

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical prep Read More

Class [016]
Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building.

Class [044]
Providing a medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, m Read More

Mark Details


Serial Number

2353852

Registered On

31 Mar 2023

Renewal On

31 Mar 2033

Mark Type

WORD

Priority Claim (Convention Details)


Date

3 Oct 2022

Mark Type

US

Legal History


Show more

Status DateAction Taken
18th Jul 2023International Registration in Australia Protected correspondence sent
17th Jul 2023IP Right Registration Published
17th Jul 2023Status change to Registered/Protected
11th May 2023Application Accepted correspondence sent
10th May 2023IP Right has been Examined
10th May 2023IP Right Acceptance Published
10th May 2023Status change to Accepted
9th May 2023Awaiting examination
9th May 2023Examination expedited
4th May 2023IP Right Filed Published